242 related articles for article (PubMed ID: 25922420)
21. Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others.
Bedi G; Hyman D; de Wit H
Biol Psychiatry; 2010 Dec; 68(12):1134-40. PubMed ID: 20947066
[TBL] [Abstract][Full Text] [Related]
22. Oxytocin receptor gene variation predicts subjective responses to MDMA.
Bershad AK; Weafer JJ; Kirkpatrick MG; Wardle MC; Miller MA; de Wit H
Soc Neurosci; 2016 Dec; 11(6):592-9. PubMed ID: 26787430
[TBL] [Abstract][Full Text] [Related]
23. Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis.
Regan A; Margolis S; de Wit H; Lyubomirsky S
PLoS One; 2021; 16(10):e0258849. PubMed ID: 34695117
[TBL] [Abstract][Full Text] [Related]
24. Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression.
Zacher A; Zimmermann J; Cole DM; Friedli N; Opitz A; Baumgartner MR; Steuer AE; Verdejo-Garcia A; Stock AK; Beste C; Quednow BB
Eur Neuropsychopharmacol; 2024 Jun; 83():43-54. PubMed ID: 38642447
[TBL] [Abstract][Full Text] [Related]
25. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
Harris DS; Baggott M; Mendelson JH; Mendelson JE; Jones RT
Psychopharmacology (Berl); 2002 Aug; 162(4):396-405. PubMed ID: 12172693
[TBL] [Abstract][Full Text] [Related]
26. MDMA Increases Cooperation and Recruitment of Social Brain Areas When Playing Trustworthy Players in an Iterated Prisoner's Dilemma.
Gabay AS; Kempton MJ; Gilleen J; Mehta MA
J Neurosci; 2019 Jan; 39(2):307-320. PubMed ID: 30455187
[TBL] [Abstract][Full Text] [Related]
27. Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships.
Schmid Y; Hysek CM; Preller KH; Bosch OG; Bilderbeck AC; Rogers RD; Quednow BB; Liechti ME
Eur Neuropsychopharmacol; 2015 Jan; 25(1):17-25. PubMed ID: 25498417
[TBL] [Abstract][Full Text] [Related]
28. MDMA: interactions with other psychoactive drugs.
Mohamed WM; Ben Hamida S; Cassel JC; de Vasconcelos AP; Jones BC
Pharmacol Biochem Behav; 2011 Oct; 99(4):759-74. PubMed ID: 21756931
[TBL] [Abstract][Full Text] [Related]
29. MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task.
Vollenweider FX; Liechti ME; Paulus MP
J Psychopharmacol; 2005 Jul; 19(4):366-74. PubMed ID: 15982991
[TBL] [Abstract][Full Text] [Related]
30. Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects.
Seibert J; Hysek CM; Penno CA; Schmid Y; Kratschmar DV; Liechti ME; Odermatt A
Neuroendocrinology; 2014; 100(1):17-25. PubMed ID: 24903002
[TBL] [Abstract][Full Text] [Related]
31. Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers.
Dumont GJ; Schoemaker RC; Touw DJ; Sweep FC; Buitelaar JK; van Gerven JM; Verkes RJ
J Psychopharmacol; 2010 Feb; 24(2):155-64. PubMed ID: 19164498
[TBL] [Abstract][Full Text] [Related]
32. Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing.
Agurto C; Cecchi GA; Norel R; Ostrand R; Kirkpatrick M; Baggott MJ; Wardle MC; Wit H; Bedi G
Neuropsychopharmacology; 2020 Apr; 45(5):823-832. PubMed ID: 31978933
[TBL] [Abstract][Full Text] [Related]
33. Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers.
Baggott MJ; Garrison KJ; Coyle JR; Galloway GP; Barnes AJ; Huestis MA; Mendelson JE
J Psychoactive Drugs; 2019; 51(2):108-117. PubMed ID: 30967099
[TBL] [Abstract][Full Text] [Related]
34. Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects.
Schmid Y; Rickli A; Schaffner A; Duthaler U; Grouzmann E; Hysek CM; Liechti ME
J Pharmacol Exp Ther; 2015 Apr; 353(1):102-11. PubMed ID: 25655950
[TBL] [Abstract][Full Text] [Related]
35. Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.
Hysek CM; Brugger R; Simmler LD; Bruggisser M; Donzelli M; Grouzmann E; Hoener MC; Liechti ME
J Pharmacol Exp Ther; 2012 Feb; 340(2):286-94. PubMed ID: 22034656
[TBL] [Abstract][Full Text] [Related]
36. MDMA and sexual behavior: ecstasy users' perceptions about sexuality and sexual risk.
McElrath K
Subst Use Misuse; 2005; 40(9-10):1461-77. PubMed ID: 16048828
[TBL] [Abstract][Full Text] [Related]
37. The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.
Hysek CM; Simmler LD; Ineichen M; Grouzmann E; Hoener MC; Brenneisen R; Huwyler J; Liechti ME
Clin Pharmacol Ther; 2011 Aug; 90(2):246-55. PubMed ID: 21677639
[TBL] [Abstract][Full Text] [Related]
38. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart.
Farré M; Tomillero A; Pérez-Mañá C; Yubero S; Papaseit E; Roset PN; Pujadas M; Torrens M; Camí J; de la Torre R
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1637-49. PubMed ID: 26073279
[TBL] [Abstract][Full Text] [Related]
39. Gender differences in the subjective effects of MDMA.
Liechti ME; Gamma A; Vollenweider FX
Psychopharmacology (Berl); 2001 Mar; 154(2):161-8. PubMed ID: 11314678
[TBL] [Abstract][Full Text] [Related]
40. (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats.
Morley KC; McGregor IS
Eur J Pharmacol; 2000 Nov; 408(1):41-9. PubMed ID: 11070182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
